Galmed Pharmaceuticals Ltd. buy Stifel Nicolaus
Start price
21.02.24
/
50%
€0.34
Target price
21.02.25
€59.19
Performance (%)
-17.65%
Price
01.08.24
€0.28
Summary
This prediction is currently active. The prediction for Galmed Pharmaceuticals Ltd. disappoints with a performance of -17.65%. This prediction currently runs until 21.02.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | 2.837% | 2.837% |
iShares Core DAX® | 0.786% | 1.251% |
iShares Nasdaq 100 | 1.855% | -2.687% |
iShares Nikkei 225® | 3.947% | 2.199% |
iShares S&P 500 | 1.787% | 0.151% |
Comments by Stifel_Nicolaus for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Stifel Nicolaus from $61.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.38
08.05.24
08.05.24
€65.08
08.05.25
08.05.25
-25.53%
01.08.24
01.08.24